Lv7
5008 积分 2021-08-24 加入
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors
14小时前
已关闭
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
12天前
已完结
Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
1个月前
已完结
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma
2个月前
已关闭
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
2个月前
已完结
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已完结
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
2个月前
已完结
Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study
3个月前
已完结
皖公网安备34019202002308
